Loading…

The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial

•Oral rotavirus vaccines underperform in low-income countries.•A double vaccine dose did not improve immune response among infants in Bangladesh.•Infants with vaccine replication had improved antibody responses.•Interventions to improve gut health and promote vaccine replication are needed. Oral, li...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2020-01, Vol.38 (1), p.90-99
Main Authors: Lee, Benjamin, Dickson, Dorothy M., Alam, Masud, Afreen, Sajia, Kader, Abdul, Afrin, Faria, Ferdousi, Tania, Damon, Christina F., Gullickson, Soyeon K., McNeal, Monica M., Bak, Daniel M., Tolba, Mona, Carmolli, Marya P., Taniuchi, Mami, Haque, Rashidul, Kirkpatrick, Beth D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•Oral rotavirus vaccines underperform in low-income countries.•A double vaccine dose did not improve immune response among infants in Bangladesh.•Infants with vaccine replication had improved antibody responses.•Interventions to improve gut health and promote vaccine replication are needed. Oral, live-attenuated rotavirus vaccines suffer from impaired immunogenicity and efficacy in low-income countries. Increasing the inoculum of vaccine might improve vaccine response, but this approach has been inadequately explored in low-income countries. We performed a double-blind, parallel group, randomized controlled trial from June 2017 through June 2018 in the urban Mirpur slum of Dhaka, Bangladesh to compare vaccine take (primary outcome) among healthy infants randomized to receive either the standard dose or double the standard dose of oral Rotarix (GlaxoSmithKline) vaccine at 6 and 10 weeks of life. Infants with congenital malformations, birth or enrollment weight
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2019.09.088